Hepatitis C and Your Eyes: What You Need to Know

Chronic hepatitis C virus (HCV) infection can affect your eyes in ways that range from persistent dryness to serious vision loss. The most common problem is dry eye syndrome, found in roughly half of people with chronic HCV, but the virus is also linked to corneal ulcers, inflammation inside the eye, retinal blood vessel disease, and even optic nerve damage. These effects stem partly from the virus itself and partly from the immune system’s overreaction to it, and some older HCV treatments carried their own eye-related risks.

Dry Eye Is the Most Common Problem

If you have chronic hepatitis C and your eyes feel gritty, irritated, or tired, dry eye syndrome is the most likely explanation. In one study of HCV-positive patients, half showed reduced tear production compared to healthy controls, and the difference was statistically significant even after accounting for age.¹ Several of those patients had surface changes on the cornea consistent with chronic dryness, including minor corneal thinning in a couple of cases.

The mechanism behind this ties back to how HCV triggers immune activity beyond the liver. The virus can provoke a Sjögren-like response, where the immune system attacks moisture-producing glands, including the tear glands. This is not full-blown Sjögren syndrome (a distinct autoimmune disease), but it mimics some of the same gland dysfunction. For many people with HCV, the dryness is mild and manageable with artificial tears. In more severe cases, the damage to the eye surface becomes a gateway to more serious corneal problems.

Corneal Ulcers and the Mooren Connection

One of the more alarming eye complications linked to hepatitis C is Mooren’s ulcer, a painful, progressive erosion of the cornea that can threaten vision. Mooren’s ulcer typically starts at the edge of the cornea and works its way inward, destroying tissue as it goes. Researchers recognized the association between HCV and this type of corneal breakdown early on: a study in Ophthalmology concluded that chronic HCV infection is associated with Mooren-type peripheral ulcerative keratitis and recommended that all patients with Mooren-type ulcers be tested for HCV.²

A separate case report described bilateral Mooren ulcers in a patient whose only identifiable underlying condition was chronic hepatitis C. Treatment with antiviral therapy (ribavirin and interferon) alongside immunosuppressive and surgical corneal management produced a full remission lasting over six years.³ That case is instructive because it shows how treating the underlying HCV infection can stabilize eye disease that would otherwise keep progressing.

Another form of corneal damage involves peripheral ulcerative keratitis driven by cryoglobulins, abnormal proteins that form in the blood of some HCV patients. In one reported case, a ring-shaped peripheral corneal ulcer with a dense white infiltrate appeared alongside mild scleritis, and blood work revealed both a high HCV viral load and type 2 cryoglobulins while other autoimmune markers came back negative.⁴ Cryoglobulinemia is one of the best-understood bridges between HCV and eye disease: the virus triggers production of these rogue immune proteins, which then deposit in small blood vessels throughout the body, including in the eye.

Inflammation Inside the Eye

HCV-related eye disease does not stop at the surface. The virus is linked to scleritis (inflammation of the tough white outer coat of the eye) and, less commonly, uveitis (inflammation of the middle layer). A clinical case documented the co-occurrence of severe dry eye, Mooren’s ulcer, and necrotizing anterior scleritis with inflammation, all affecting both eyes, in a patient with chronic HCV.⁵ Necrotizing scleritis is particularly concerning because it can destroy the scleral tissue and, left unchecked, perforate the eye.

Deeper still, the retina can become a target. Retinal vasculitis, where the immune system attacks the blood vessels lining the back of the eye, has been reported in HCV patients. The inflammation shows up as perivascular sheaths visible on angiography, and it can impair vision if the affected vessels supply the central retina.⁶ Vitreitis, inflammation of the gel that fills the eye, can accompany this process and produce floaters or a general haziness in vision.

The thread connecting these different forms of inflammation is the immune dysregulation HCV provokes. The virus does not typically invade eye tissue directly in large amounts. Instead, it stirs up immune complexes and autoantibodies that travel through the bloodstream and settle in ocular tissues. Cryoglobulinemia is the most well-characterized of these pathways, but other immune mechanisms are probably at play as well, since not every HCV patient with eye inflammation tests positive for cryoglobulins.

Optic Nerve Damage

Among the rarer but more frightening eye complications of hepatitis C is optic neuritis, inflammation of the optic nerve that can cause rapid vision loss. A case report described a 34-year-old woman who developed bilateral optic neuritis just two weeks after the onset of acute hepatitis C. The tight timing between the liver infection and the nerve inflammation made a strong case that HCV caused the optic neuritis.⁷

Optic neuritis typically presents as sudden blurring or dimming in one or both eyes, often with pain when moving the eyes. While many people associate optic neuritis with multiple sclerosis, a range of viral infections can trigger it, and HCV is among them. Ischemic optic neuropathy, where reduced blood flow damages the optic nerve, has also been described in HCV patients.⁸ The distinction matters clinically because ischemic damage is usually permanent, whereas inflammatory optic neuritis may improve with treatment.

Interferon Treatment and Retinopathy

For years, the standard treatment for hepatitis C was interferon-based therapy, and that treatment itself could damage the eyes. Interferon retinopathy, marked by cotton wool spots and retinal hemorrhages, was a recognized side effect. In one study of 100 patients receiving interferon therapy for HCV, 16 developed retinopathy. Three-quarters of those cases affected both eyes, and most were first detected by the appearance of cotton wool spots.⁹

Other research found even higher rates. One study reported that about 31% of patients on pegylated interferon developed retinopathy, and having high blood pressure substantially raised the risk.¹⁰ That study’s authors argued that ophthalmologic screening was justified for HCV patients on interferon, particularly those with hypertension or diabetes. The retinopathy typically resolved after interferon was stopped, but in some patients it progressed enough to cause lasting vision problems before it was caught.

The practical relevance of interferon retinopathy has faded considerably since direct-acting antiviral drugs replaced interferon as the standard of care for hepatitis C in most countries. These newer medications cure HCV in the vast majority of patients within 8 to 12 weeks and do not carry the same retinal risks. However, interferon is still used in some settings, and anyone who received it in the past should be aware that unexplained visual symptoms during or after treatment might have been related to the drug.¹¹

Can HCV Spread Through Tears?

This question comes up because HCV is a blood-borne virus, and tears are a body fluid that eye-care professionals regularly encounter. The same study that documented dry eye in half of HCV patients also tested tear samples for viral genetic material and found HCV RNA in about 10% of them. The viral levels in tears were far lower than in blood, roughly 50 times lower on average, but the presence of any virus raises the question of whether tears could be a transmission route.¹

In practical terms, the risk of catching hepatitis C from someone’s tears is extremely low. The virus concentrations detected were small, and real-world transmission of HCV requires a meaningful amount of virus entering the bloodstream, usually through shared needles, contaminated medical equipment, or (less efficiently) sexual contact. Still, the finding has implications for eye-care settings. Ophthalmologists and optometrists handling instruments that touch the eye surface should follow standard infection-control practices. Tonometry tips, contact lenses used for exams, and surgical instruments all warrant careful disinfection, which is standard practice regardless of a patient’s HCV status.

Why Eye Symptoms Can Be Misdiagnosed

One of the tricky aspects of HCV-related eye disease is that many of these conditions look identical to their non-HCV counterparts. Mooren’s ulcer, scleritis, retinal vasculitis, and optic neuritis all occur in people who do not have hepatitis C. If a doctor does not think to test for HCV, the connection can be missed entirely.

A case published in Clinical Medicine illustrates this well. A man with hepatitis C presented with acute vision loss over three days. The initial evaluation pointed toward idiopathic orbital inflammatory syndrome, a diagnosis that essentially means “we see inflammation but don’t know why.” Treatment with steroids and antivirals initially improved his vision. But after he was lost to follow-up and stopped treatment, his vision deteriorated again, and re-evaluation revealed marginal zone B-cell lymphoma, a type of cancer linked to chronic HCV-driven immune stimulation.¹² The case underscores that HCV-related eye problems are not always benign inflammatory conditions. Chronic immune activation from the virus can, in rare cases, drive the development of lymphoma in or around the eye.

For you, the takeaway is straightforward: if you have hepatitis C and develop any new eye symptoms, let your eye doctor know about your HCV status, even if the symptoms seem unrelated. And if you develop an unexplained corneal ulcer, scleritis, or retinal vasculitis, it is reasonable to ask whether HCV testing has been done if your status is unknown.

Does Curing Hepatitis C Fix the Eye Problems?

The evidence here is encouraging but mixed, and it depends on which eye complication you are talking about. Conditions driven by active immune dysregulation, like cryoglobulinemic vasculitis and some forms of scleritis, tend to improve or resolve when the virus is cleared. The bilateral Mooren ulcer case mentioned earlier went into lasting remission after antiviral treatment.³ Cases where antiviral treatment improved visual outcomes have also been reported alongside steroid therapy.¹²

Dry eye, on the other hand, may not fully reverse even after sustained virologic response (the clinical term for a confirmed cure). If the tear glands have sustained lasting damage from years of immune-mediated inflammation, clearing the virus removes the ongoing trigger but does not necessarily repair the gland tissue. Similarly, any structural damage to the cornea, retina, or optic nerve that occurred before treatment may be permanent. The message is familiar in medicine: earlier treatment tends to produce better outcomes. This applies to the eyes as much as to the liver.

Medications Used Alongside HCV Treatment and Eye Safety

People with HCV-related eye complications often need immunosuppressive drugs to calm the inflammation while antiviral therapy addresses the root cause. Corticosteroids are the first-line choice for acute flares of scleritis, uveitis, and optic neuritis. Long-term steroid use, however, carries its own ocular risks, primarily cataracts and glaucoma. These are well-known side effects of chronic corticosteroid use across all medical conditions, not specific to HCV treatment.

When steroids are not enough or need to be tapered, steroid-sparing immunosuppressants like methotrexate or mycophenolate may be used. Some of these drugs have their own potential for eye toxicity, and chronic administration even at recommended doses can cause ocular side effects that require monitoring.¹³ If you are on any of these medications, periodic eye exams are a reasonable precaution even if you feel fine.

Who Should Get an Eye Exam

There is no universal guideline mandating eye screening for every person with hepatitis C, partly because the more serious eye complications are uncommon. But several situations warrant a trip to the ophthalmologist:

New visual symptoms: Any sudden blurring, dimming, floaters, eye redness, or pain should be evaluated promptly, especially if it develops over days rather than weeks.
Chronic dry eye: If over-the-counter drops are not keeping your eyes comfortable, an ophthalmologist can assess whether HCV-related gland damage is involved and offer more targeted treatments.
Interferon history: If you received interferon-based therapy in the past, mention it at your next eye exam. Retinal changes from interferon are usually reversible but occasionally leave lasting marks.
Known cryoglobulinemia: Cryoglobulins are the main pathway through which HCV damages blood vessels in the eye. If your blood work has ever shown cryoglobulins, regular eye monitoring makes sense.
Autoimmune overlap: If you have been diagnosed with Sjögren syndrome, rheumatoid arthritis, or another autoimmune condition alongside HCV, the combined immune burden puts your eyes at higher risk.

The underlying principle is that hepatitis C is a systemic disease, not just a liver disease. Its effects can show up in the kidneys, skin, joints, nervous system, and eyes. Awareness of the eye connection is still surprisingly low among both patients and some clinicians, which is exactly why odd eye symptoms in someone with HCV deserve a closer look rather than an assumption that the two are unrelated.

1
American Journal of Ophthalmology. Ocular Surface Changes and Presence of Hepatitis C Virus in Tears of Patients With Chronic Hepatitis C Virus Infection
2
PubMed. Mooren-type hepatitis C virus-associated corneal ulceration
3
PubMed Central. Case report: bilateral Mooren ulcer in association with hepatitis C
4
PubMed Central. Peripheral Ulcerative Keratitis Associated with HCV-Related Cryoglobulinemia
5
PubMed Central. Ophthalmological implications of the chronic infections with the hepatitis C Virus
6
JAMA Network. Retinal Vasculitis and Vitreitis in a Patient With Chronic Hepatitis C Virus
7
PubMed. Bilateral optic neuritis in acute hepatitis C
8
PubMed. Ocular manifestations during hepatitis C infection
9
PubMed Central. Retinopathy associated with interferon therapy in patients with hepatitis C virus
10
PubMed. Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening
11
PubMed Central. Is screening for interferon retinopathy in hepatitis C justified?
12
PubMed Central. Lessons of the month 2: Ocular manifestations and complications of hepatitis C infection
13
PubMed Central. Ocular side effects of anti-rheumatic medications: what a rheumatologist should know